| LIFE |
Ethos Technologies Inc. |
Wang Lingke |
|
2026-01-30 |
C - D |
291,545 |
0.00 |
0.00 |
0 |
| LIFE |
Ethos Technologies Inc. |
Wang Lingke |
|
2026-01-30 |
C - D |
291,545 |
0.00 |
0.00 |
0 |
| LIFE |
Ethos Technologies Inc. |
Wang Lingke |
|
2026-01-30 |
C - D |
291,544 |
0.00 |
0.00 |
0 |
| LIFE |
Ethos Technologies Inc. |
Wang Lingke |
|
2026-01-30 |
C - D |
291,544 |
0.00 |
0.00 |
0 |
| LIFE |
Ethos Technologies Inc. |
Wang Lingke |
|
2026-01-30 |
C - D |
291,544 |
0.00 |
0.00 |
0 |
| LIFE |
Ethos Technologies Inc. |
Wang Lingke |
|
2026-01-30 |
C - A |
3,943,281 |
0.00 |
0.00 |
3,943,281 |
| LIFE |
Ethos Technologies Inc. |
Wang Lingke |
|
2026-01-30 |
C - A |
64,043 |
0.00 |
0.00 |
64,043 |
| LIFE |
Ethos Technologies Inc. |
Wang Lingke |
|
2026-01-30 |
C - A |
388,726 |
0.00 |
0.00 |
388,726 |
| LIFE |
Ethos Technologies Inc. |
Wang Lingke |
|
2026-01-30 |
C - A |
291,545 |
0.00 |
0.00 |
291,545 |
| LIFE |
Ethos Technologies Inc. |
Wang Lingke |
|
2026-01-30 |
C - A |
291,545 |
0.00 |
0.00 |
291,545 |
| LIFE |
Ethos Technologies Inc. |
Wang Lingke |
|
2026-01-30 |
C - A |
291,545 |
0.00 |
0.00 |
291,545 |
| LIFE |
Ethos Technologies Inc. |
Wang Lingke |
|
2026-01-30 |
C - A |
291,544 |
0.00 |
0.00 |
291,544 |
| LIFE |
Ethos Technologies Inc. |
Wang Lingke |
|
2026-01-30 |
C - A |
291,544 |
0.00 |
0.00 |
291,544 |
| LIFE |
Ethos Technologies Inc. |
Wang Lingke |
|
2026-01-30 |
C - A |
291,544 |
0.00 |
0.00 |
291,544 |
| CTNM |
Contineum Therapeutics, Inc. |
Watkins Tim |
Officer
|
2026-01-30 |
A - A |
160,000 |
0.00 |
0.00 |
160,000 |
| CIVI |
CIVITAS RESOURCES, INC. |
Willard Howard A. |
Director
|
2026-01-30 |
D - D |
50,317 |
0.00 |
0.00 |
0 |
| CIVI |
CIVITAS RESOURCES, INC. |
Wojahn Jeff E |
Director
|
2026-01-30 |
D - D |
48,847 |
0.00 |
0.00 |
0 |
| DAWN |
Day One Biopharmaceuticals, Inc. |
York Charles N II |
|
2026-01-30 |
A - A |
188,000 |
0.00 |
0.00 |
188,000 |
| DAWN |
Day One Biopharmaceuticals, Inc. |
York Charles N II |
|
2026-01-30 |
A - A |
126,000 |
0.00 |
0.00 |
126,000 |
| NRIX |
Nurix Therapeutics, Inc. |
van Houte Hans |
Officer
|
2026-01-30 |
M - A |
2,887 |
0.00 |
0.00 |
40,479 |
| NRIX |
Nurix Therapeutics, Inc. |
van Houte Hans |
Officer
|
2026-01-30 |
M - A |
2,000 |
0.00 |
0.00 |
42,479 |
| NRIX |
Nurix Therapeutics, Inc. |
van Houte Hans |
Officer
|
2026-01-30 |
M - A |
3,750 |
0.00 |
0.00 |
46,229 |
| NRIX |
Nurix Therapeutics, Inc. |
van Houte Hans |
Officer
|
2026-01-30 |
M - A |
2,859 |
0.00 |
0.00 |
49,088 |
| NRIX |
Nurix Therapeutics, Inc. |
van Houte Hans |
Officer
|
2026-01-30 |
S - D |
3,588 |
16.58 |
59,498.37 |
45,500 |
| NRIX |
Nurix Therapeutics, Inc. |
van Houte Hans |
Officer
|
2026-01-30 |
S - D |
73 |
17.37 |
1,268.13 |
45,427 |